The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis

Hagop Kantarjian, Susan O'Brien, Jorge Cortes, Francis Giles, Stefan Faderl, Elias Jabbour, Guillermo Garcia-Manero, William Wierda, Sherry Pierce, Jianqin Shan, Elihu Estey, Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. ,vol. 106, pp. 1090- 1098 ,(2006) , 10.1002/CNCR.21723

Guillaume Lessene, Peter E. Czabotar, Peter M. Colman, BCL-2 family antagonists for cancer therapy Nature Reviews Drug Discovery. ,vol. 7, pp. 989- 1000 ,(2008) , 10.1038/NRD2658

R Valdez, J Camoriano, V Fauble, R E Tiedemann, Y H Qiu, K R Coombes, M Cardone, E Braggio, H Yin, D O Azorsa, R A Mesa, A K Stewart, R Tibes, J M Bogenberger, S M Kornblau, W E Pierceall, R Lena, D Chow, C-X Shi, J Mantei, G Ahmann, I M Gonzales, A Choudhary, BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies Leukemia. ,vol. 28, pp. 1657- 1665 ,(2014) , 10.1038/LEU.2014.44

Julian PT Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman, Measuring inconsistency in meta-analyses BMJ. ,vol. 327, pp. 557- 560 ,(2003) , 10.1136/BMJ.327.7414.557

Bruce D Cheson, Peter L Greenberg, John M Bennett, Bob Lowenberg, Pierre W Wijermans, Stephen D Nimer, Antonio Pinto, Miloslav Beran, Theo M De Witte, Richard M Stone, Moshe Mittelman, Guillermo F Sanz, Steven D Gore, Charles A Schiffer, Hagop Kantarjian, Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia Blood. ,vol. 108, pp. 419- 425 ,(2006) , 10.1182/BLOOD-2005-10-4149

Antonio M. Almeida, Fernando Ramos, Acute myeloid leukemia in the older adults Leukemia research reports. ,vol. 6, pp. 1- 7 ,(2016) , 10.1016/J.LRR.2016.06.001

Chong Gao, Jia Wang, Ya Li, Huan Zhao, Ruibai Li, Li Hou, Yayue Zhang, Shaodan Tian, Huan Liang, Chong Wang, Xinyi Chen, Jing Wang, Incidence and risk of hematologic toxicities with hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukopenia: A systematic review and meta-analysis. Medicine. ,vol. 97, ,(2018) , 10.1097/MD.0000000000011860

Courtney D. DiNardo, Keith Pratz, Vinod Pullarkat, Brian A. Jonas, Martha Arellano, Pamela S. Becker, Olga Frankfurt, Marina Konopleva, Andrew H. Wei, Hagop M. Kantarjian, Tu Xu, Wan-Jen Hong, Brenda Chyla, Jalaja Potluri, Daniel A. Pollyea, Anthony Letai, Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. ,vol. 133, pp. 7- 17 ,(2019) , 10.1182/BLOOD-2018-08-868752

Ibrahim Aldoss, Dongyun Yang, Raju Pillai, James F. Sanchez, Matthew Mei, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Monzr M. Al Malki, Amandeep Salhotra, Samer Khaled, Weili Sun, Margaret O'Donnell, David Snyder, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat, Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia American Journal of Hematology. ,vol. 94, ,(2019) , 10.1002/AJH.25567

Amanda C Winters, Jonathan A Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T Schowinsky, Julie Rosser, Mark D Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M Stevens, Craig T Jordan, Clayton Smith, Daniel A Pollyea, None, Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia Blood Advances. ,vol. 3, pp. 2911- 2919 ,(2019) , 10.1182/BLOODADVANCES.2019000243